David Essayan, M.D., FACP

Head of Regulatory Affairs

David serves as Equillium’s Head of Regulatory Affairs. He is Executive Vice President of ONCORD, a clinical and regulatory consulting firm based in southern California. Prior to ONCORD, David served as Executive Director of Regulatory Affairs at Amgen, with global responsibility for products in the Inflammation and General Medicine therapeutic areas; he is also a former Supervisory Medical Officer in the Office of Therapeutics Research and Review and Principal Investigator in the Laboratory of Tumor Molecular Biology, both at CBER/FDA.

David received his Bachelor of Science in Chemistry from Yale University, M.D. from the University of Pennsylvania, completed his residency in Internal Medicine at Temple University Hospital and completed his fellowship in Allergy and Clinical Immunology at the Johns Hopkins University School of Medicine, where he served as faculty for 12 years.